Introduction
============

Keratoconus (KTCN; OMIM [148300](http://www.ncbi.nlm.nih.gov/omim/148300)) is a non-inflammatory thinning and anterior protrusion of the cornea that results in steepening and distortion of the cornea, altered refractive powers and altered visual acuity. In more advanced cases, corneal scarring from corneal edema and decompensation further reduces visual acuity. Symptoms are highly variable and depend on the stage of progression of the disorder \[[@r1],[@r2]\]. The prevalence of keratoconus has been reported to vary in different studies, from 8.8 to 54.4 per 100,000 \[[@r3],[@r4]\], the variation is in part due to the different diagnostic criteria used. The incidence of keratoconus ranges between 1/500 to 1/2,000 individuals throughout the world \[[@r5]\]. The disease occurs with no ethnic or gender preponderance and causes significant visual impairment \[[@r2],[@r5],[@r6]\]. Keratoconus should be divided into three broad categories: i) keratoconus associated with rare genetic disorders (such as Down syndrome, nail-patella syndrome, neurofibromatosis, etc); ii) keratoconus in the setting of commonly reported associations (contact lens wear, eye rubbing, atopy, Leber congenital amaurosis, mitral valve prolapsed and positive family history) and iii) isolated keratoconus with no associations. Most cases of keratoconus are sporadic but some (5%--10%) have a positive family history \[[@r6],[@r7]\]. In such cases both autosomal recessive and dominant patterns of inheritance have been reported \[[@r8]-[@r11]\]. There are several chromosomal loci and genes reported to be associated with keratoconus \[[@r6],[@r11]\]. some of which were eventually excluded \[[@r6],[@r12]\], while others showed no confirmed association with the disease \[[@r13],[@r14]\]. This is not the case for the visual system homebox 1 (*VSX1*) gene where mutations associated with keratoconus cases have been found in different studies \[[@r15]-[@r18]\], although other studies which did not find *VSX1* mutations in cohorts of keratoconus patients from various populations \[[@r19],[@r20]\]. This indicates that keratoconus is a complex condition of multi-factorial etiology and that mutations in *VSX1* are not responsible for all cases of keratoconus. To our knowledge, this is the first time *VSX1* was screened for mutations in the Saudi keratconus patients.

Methods
=======

Patients and controls
---------------------

The study adheres to the tenets of the Declaration of Helsinki, and all participants signed an informed consent. The study was approved by the College of Medicine (King Saud University, Riyadh, Saudi Arabia) ethical committee (proposal number \# 09--659). All study subjects were self identified of Saudi Arabian ethnicity. Family names were all present in the database of Arab families of Saudi Arabian origin. In this study we screened 55 unrelated Saudi Keratoconus patients (each patient represents one family) and 50 ethnically matched unrelated controls for mutations in the *VSX1* gene. Patients were selected from the anterior segment clinic at King Abdulaziz University Hospital after examination. Patients were diagnosed with keratoconus if the Schimpff-flow based elevation map showed posterior corneal elevation within the central 5 mm ≥+20 µm, inferior-superior dioptric asymmetry (I-S value) \>1.2 diopters (D) and the steepest keratometrey \>47 D. Patients were considered as sporadic cases after examining the immediate family members and identifying the patient as isolated case of keratoconus. Exclusion criteria was based on presence of post- laser-assisted in situ keratomileusis (LASIK) ectasia and refusal to participate.

Controls were recruited from the general ophthalmology clinic and had no ocular disease(s) or previous ophthalmic surgeries. Their slit lamp exam showed clear cornea and their Schimpff-flow based elevation map were within normal limits.

All Keratoconus cases secondary to causes such as trauma, surgery, Ehlers Danlos syndrome, Osteogenesis Imperfecta and pellucid marginal degeneration were excluded from the study.

DNA analysis
------------

Five milliliters of peripheral blood were collected in EDTA tubes from all participating individuals. DNA was extracted using the illustra blood genomicPrep Mini Spin Kit from GE Healthcare (Buckinhamshire, UK), and stored at --20 °C in aliquots until required. PCR amplification of the *VSX1* coding region were performed using the primers detailed in [Table 1](#t1){ref-type="table"}. Successfully amplified fragments were sequenced in both directions using the M13 forward and reverse primers and the BigDye terminator v3.1 cycle sequencing kit (Applied Biosystems, Foster city, CA). Fragments were then run on the 3130xl Genetic Analyzer (Applied Biosystems) according to the manufacturer protocol. All sequenced fragments were analyzed using SeqScape software v2.6 (Applied Biosystems) and compared to the *VSX1* reference sequence (GenBank [NG_008101](http://www.ncbi.nlm.nih.gov/nuccore/NG_008101)).

###### Primer sequences, PCR annealing temperature, and amplicon size for *VSX1* PCR amplification.

  **Exon**    **Primer sequence**                               **Annealing temperature (°C)**
  ----------- ------------------------------------------------- --------------------------------
  VSX1--1F    **TGTAAAACGACGGCCAGT**CAGCTGATTGGAGCCCTTC         60
  VSX1--1R    **CAGGAAACAGCTATGACC**GGGGCGATGGTCTGTGAC           
  VSX1--2F    **TGTAAAACGACGGCCAGT**CCCAAGAGGTTCATAACTTCAA      60
  VSX1--2R    **CAGGAAACAGCTATGACC**TATCATGCCGGGCCATAAAT         
  VSX1--3aF   **TGTAAAACGACGGCCAGT**CTGGACAGCAGAGGAAGCA         60
  VSX1--3aR   **CAGGAAACAGCTATGACC**TTGGCTATAGAGAAGGGACTGC       
  VSX1--3bF   **TGTAAAACGACGGCCAGT**TGGACAGCAGAGGAAGCAG         60
  VSX1--3bR   **CAGGAAACAGCTATGACC**TCAGGGGCAGATAATATACTCCA      
  VSX1--4F    **TGTAAAACGACGGCCAGT**GCCCCTCTTCACTGTCTCTTC       60
  VSX1--4R    **CAGGAAACAGCTATGACC**TTGCTTTGCTTTGGAAATGG         
  VSX1--5aF   **TGTAAAACGACGGCCAGT**TGGGATTTAGAGAACAATAAGAAGG   58
  VSX1--5aR   **CAGGAAACAGCTATGACC**CAGTGAAATCATTTTTGAACTTCG     
  VSX1--5bF   **TGTAAAACGACGGCCAGT**CAGATGAGTGACCTAGGGAAAA      57
  VSX1--5bR   **CAGGAAACAGCTATGACC**TGTCACATGTCCCCAGATTG         

F: Forward; R: Reverse; Bold sequences are those of the M13.

Results
=======

Fifty-five unrelated Keratoconus patients ([Table 2](#t2){ref-type="table"}) and 50 unrelated controls were recruited into this study. Of the 55 Keratoconus patients there were 24 males and 31 females with a mean age of 28.9 (SD 7.7). Of the 50 controls there were 19 males and 31 females with a mean age of 60 (SD 17). Examining the family pedigrees in the keratoconus patients indicated that the mode of inheritance was sporadic in 56.4% of cases, 34.6% were autosomal recessive; 5.4% were autosomal dominant, and 3.6% of cases were indeterminable **(**[Table 2](#t2){ref-type="table"}**)**. The full coding region, exon-intron boundaries and the 5′UTR and 3′UTR of *VSX1* was sequenced in all subjects. We detected five nucleotide changes in both patients and controls ([Table 3](#t3){ref-type="table"}). Two were previously reported ([rs8123716](http://www.ncbi.nlm.nih.gov/snp?term=rs8123716) and [rs12480307](http://www.ncbi.nlm.nih.gov/snp?term=rs12480307); and three are novel; [Table 3](#t3){ref-type="table"}). Three of the sequence changes g.5053 G\>T, g.8326 G\>A, and g.11059 A\>C were heterozygous and two were homozygous (g.8222 A\>G and g.10945 G\>T). None of the sequence changes detected were pathogenic. Two (g.5053 G\>T and g.8222 A\>G) were synonymous coding, one intronic (g.8326 G\>A), and two (g.10945 G\>T and g.11059 A\>C) in the 3′ UTR region.

###### Clinical phenotypes of keratoconus patients.

  **Patient demographics**   **Uncorrected visual acuity in Snellen\'s chart**   **Munsen sign**   **Vogt\'s striae**   **Hydrops**   **Scarring**   **Average Keratometry in VKG (in Diopters)**   **Optical pachymetry (mm)**                                                      
  -------------------------- --------------------------------------------------- ----------------- -------------------- ------------- -------------- ---------------------------------------------- ----------------------------- ---- ---- ---- ---- ---- ------ ------ ----- ----- ----
  1                          20                                                  M                 20/100               20/200        \+             \+                                             \+                            \+   \+   \+   \-   \+   51.9   64.7   525   502   SP
  2                          37                                                  F                 20/200               20/400        \+             \+                                             \+                            \+   \-   \-   \+   \+   68.6   81.3   282   160   AR
  3                          18                                                  M                 CF                   20/80         \-             \-                                             \+                            \+   \+   \+   \+   \-   58     56     300   346   SP
  4                          17                                                  M                 CF                   20/100        \+             \-                                             \+                            \+   \-   \-   \-   \-   60     56.6   455   509   SP
  5                          35                                                  F                 20/20                20/60         \-             \-                                             \-                            \+   \-   \+   \-   \+   43.1   44.6   584   554   SP
  6                          30                                                  M                 20/200               CF            \-             \-                                             \-                            \-   \-   \-   \-   \-   49.1   68.7   434   349   SP
  7                          36                                                  M                 20/100               20/100        \-             \-                                             \-                            \-   \+   \+   \-   \-   48.4   50.4   459   439   SP
  8                          16                                                  M                 CF                   CF            \+             \+                                             \+                            \+   \+   \+   \-   \+   54.4   55     241   268   SP
  9                          24                                                  M                 CF                   20/80         \+             \+                                             \+                            \+   \+   \+   \+   \+   53     65.7   302   397   SP
  10                         25                                                  F                 CF                   CF            \+             \+                                             \+                            \+   \-   \-   \+   \-   67.3   70.7   236   216   SP
  11                         25                                                  M                 20/20                CF            \-             \+                                             \-                            \+   \-   \+   \-   \-   43.1   50.9   419   407   SP
  12                         46                                                  F                 20/80                20/100        \-             \-                                             \+                            \+   \+   \+   \-   \-   53     57.6   463   412   ND
  13                         32                                                  F                 20/40                20/40         \+             \+                                             \+                            \+   \+   \+   \-   \-   43.5   51.7   442   398   SP
  14                         24                                                  F                 20/100               20/60         \-             \-                                             \+                            \+   \-   \+   \-   \-   43.2   45.8   484   464   AR
  15                         30                                                  F                 20/20                20/100        \-             \-                                             \+                            \+   \-   \+   \-   \-   44.6   46.9   493   397   AR
  16                         20                                                  F                 20/25                20/100        \-             \-                                             \-                            \+   \-   \+   \-   \-   42.7   56.2   509   456   SP
  17                         32                                                  F                 CF                   20/200        \-             \-                                             \-                            \-   \+   \+   \-   \-   56.3   52.6   429   471   SP
  18                         17                                                  F                 CF                   20/25         \+             \+                                             \+                            \-   \+   \+   \+   \+   69.3   45.5   284   522   SP
  19                         24                                                  F                 20/200               CF            \-             \+                                             \-                            \+   \+   \+   \-   \+   49.8   62.2   492   218   SP
  20                         39                                                  F                 20/200               20/200        \-             \-                                             \-                            \-   \+   \+   \-   \-   49.2   53.1   458   419   SP
  21                         28                                                  F                 CF                   CF            \+             \+                                             \+                            \-   \+   \+   \+   \+   67.6   61.8   327   287   AR
  22                         40                                                  F                 20/60                20/100        \-             \-                                             \-                            \-   \-   \+   \-   \-   45.8   46.2   538   520   AD
  23                         32                                                  F                 20/60                CF            \-             \+                                             \+                            \+   \+   \+   \-   \+   48.7   43.5   427   558   AD
  24                         25                                                  M                 20/40                CF            \+             \+                                             \+                            \+   \+   \+   \-   \+   42.8   43.7   482   511   SP
  25                         17                                                  F                 20/60                20/100        \+             \+                                             \-                            \+   \+   \+   \-   \-   56.4   58.2   411   414   SP
  26                         32                                                  F                 20/100               20/100        \+             \+                                             \-                            \-   \+   \+   \-   \-   47.3   50.4   459   435   AR
  27                         22                                                  F                 20/100               20/100        \-             \-                                             \-                            \-   \+   \+   \-   \-   46.4   44.5   425   416   SP
  28                         40                                                  M                 20/100               CF            \+             \+                                             \+                            \+   \+   \+   \+   \-   69.2   71.8   262   359   AR
  29                         23                                                  F                 20/20                20/20         \-             \-                                             \-                            \-   \-   \-   \-   \-   41.8   41.8   527   526   ND
  30                         35                                                  F                 CF                   CF            \-             \-                                             \-                            \-   \-   \-   \-   \-   43.6   63.1   482   371   SP
  31                         24                                                  M                 CF                   CF            \+             \+                                             \-                            \-   \+   \+   \-   \-   47.5   66     589   158   AR
  32                         25                                                  M                 CF                   CF            \+             \+                                             \+                            \+   \+   \+   \+   \+   61.8   62.6   384   379   AR
  33                         35                                                  F                 20/200               20/200        \-             \-                                             \-                            \-   \-   \-   \-   \-   55.5   54.1   434   448   AR
  34                         25                                                  M                 20/30                20/100        \-             \+                                             \-                            \+   \-   \+   \-   \-   44.2   63.2   477   405   AR
  35                         22                                                  M                 20/80                20/30         \-             \-                                             \-                            \-   \+   \+   \-   \-   46.6   43.9   514   552   SP
  36                         25                                                  M                 20/200               CF            \-             \+                                             \-                            \+   \-   \+   \-   \+   46     49     582   397   AR
  37                         30                                                  M                 20/30                CF            \-             \-                                             \-                            \-   \-   \-   \-   \-   44     54.6   300   300   SP
  38                         40                                                  F                 20/200               CF            \-             \-                                             \-                            \-   \-   \-   \-   \-   57.1   56.6   441   457   AR
  39                         28                                                  M                 20/200               20/100        \-             \-                                             \-                            \-   \-   \-   \-   \-   50     57.7   435   388   AR
  40                         30                                                  M                 20/200               20/200        \-             \-                                             \-                            \-   \-   \-   \-   \-   46.6   46.2   519   509   AR
  41                         29                                                  F                 20/100               20/40         \-             \-                                             \-                            \-   \+   \+   \-   \-   47.4   43.6   446   495   SP
  42                         32                                                  F                 20/28                20/20         \-             \-                                             \-                            \-   \-   \-   \-   \-   46     46.8   491   471   SP
  43                         29                                                  F                 20/200               20/100        \-             \-                                             \-                            \-   \-   \-   \-   \-   47.8   46.4   516   512   SP
  44                         29                                                  F                 20/28                20/60         \-             \-                                             \-                            \-   \-   \-   \-   \-   58.7   53.7   246   374   AD
  45                         24                                                  M                 20/200               20/60         \-             \-                                             \-                            \-   \+   \+   \-   \-   49.8   45.9   467   487   SP
  46                         35                                                  F                 20/28                CF            \-             \-                                             \-                            \-   \-   \+   \-   \-   47     47.1   546   508   SP
  47                         24                                                  F                 20/20                20/28         \-             \-                                             \-                            \-   \-   \+   \-   \-   42.4   44.1   511   470   SP
  48                         40                                                  F                 CF                   20/30         \+             \+                                             \+                            \+   \+   \+   \+   \+   53.5   52     422   421   SP
  49                         23                                                  M                 20/200               20/80         \-             \-                                             \-                            \-   \-   \-   \-   \-   57.9   47.3   365   464   AR
  50                         22                                                  M                 20/100               CF            \-             \+                                             \-                            \+   \+   \+   \-   \+   45.6   68.5   491   381   SP
  51                         28                                                  M                 20/80                20/80         \+             \+                                             \+                            \+   \+   \+   \-   \-   45.9   42.6   441   453   AR
  52                         41                                                  M                 20/28                20/100        \-             \-                                             \-                            \-   \-   \-   \-   \-   43.3   46.4   494   474   SP
  53                         50                                                  M                 20/40                20/40         \+             \+                                             \+                            \+   \+   \+   \-   \-   42.9   43.4   492   476   AR
  54                         40                                                  F                 CF                   CF            \+             \+                                             \+                            \+   \+   \+   \+   \+   57.6   53.4   225   242   AR
  55                         23                                                  F                 20/60                20/20         \-             \-                                             \-                            \-   \+   \-   \-   \-   48.1   44.7   465   515   AR

Key: M=Male; F=Female; OD=Right eye; OS=Left eye; +=Positive; -=Negative; VKG=Videokeratography; AD=Autosomal dominant; AR=Autosomal recessive; SP=Sporadic; ND=not determined due to difficulty in predicting the mode of inheritance from available family pedigree. \*Mode of inheritance was established (when possible) by examining the family pedigree carefully and taking detailed family history up to 2--3 generations.

###### *VSX1* sequence changes observed in keratoconus patients and controls.

  **Nucleotide change**   **Codon change**   **Location on the gene**   **Patients (n=55)**   **Controls (n=50)**
  ----------------------- ------------------ -------------------------- --------------------- ---------------------
  g.5053 G\>T             p.S6S              Exon 1                     2 (3.6%)              2 (4%)
  g.8222 A\>G             p.A182A            Exon 3                     1 (1.8%)              1 (2%)
  g.8326 G\>A             Non-coding         Intron 3                   1 (1.8%)              5 (10%)
  g.10945 G\>T            Non-coding         3′UTR                      0                     1 (2%)
  g.11059 A\>C            Non-coding         3′UTR                      1 (1.8%)              0

Key: UTR=untranslated region. Nucleotide are numbered as in GenBank accession number [NG_008101](http://www.ncbi.nlm.nih.gov/nuccore/NG_008101).

Discussion
==========

We detected five nucleotide changes in both the patients and control groups-none of which were pathogenic. Similar results have been published recently \[[@r19]\]. The lack of pathogenic sequence changes in *VSX1* in our keratoconus cohort, indicates that *VSX1* mutations are not responsible for keratoconus cases in this population. VSX1 is amemeber of the Vsx1 group of vertebrate paired-like homeodomian transcripition factors. It has been localized to the human chromosome 20p11-q11. *VSX1* is considered important in ocular development and is particularly involved in the developing cornea. Expression in human was demonstrated in embryonic craniofacial, adult cornea and adult retinal cDNA libraries \[[@r21]\]. *VSX1* mRNA has been found in the outer tier of the inner nuclear layer of the human retina and the cornea \[[@r22]\]. Thus far, mutations reported in this gene such as p.H244R, p.G160D, p.D144E, p.P247R, p.L159M, and p.R166W have been reported in various ethnic groups, but a definite pathogenic role has not been established \[[@r23]\]. *VSX1* mutations are also associated with posterior polymorphous dystrophy \[[@r24]\]. For these aforementioned reasons, the direct link of *VSX1* with keratoconus is controversial. This suggest that other loci, such as 13q32 \[[@r25]\], may be involved in the pathogenesis of keratoconus.

In our patient group, we noticed that females were more affected than males. In the literature, it is unclear whether significant differences between males and females exist. Some studies have not found differences in the prevalence between genders \[[@r7],[@r26]\]; others have found a greater prevalence in females \[[@r27],[@r28]\]; while other investigators have found a greater prevalence in males.

In the literature, most cases of keratoconus are sporadic, but a proportion (5%--10%) may be familial \[[@r6],[@r7]\]. In our population, as judged by the family pedigree, 56.4% of cases were sporadic, 34.6% had autosomal recessive mode of inheritance, 5.4% were autosomal dominant, and 3.6% of cases were difficult to determine. So 40% (22 patients) of our keratoconus cohort were familial and this percentage is higher than that reported previously in the literature. This high rate of familial cases, could be attributed to the soaring scale of consanguinity in this society which reaches up to 60% in some areas of the Kingdom \[[@r29]\].

In the literature, 90% of pedigrees with familial keratoconus display an autosomal dominant inheritance with reduced penetrance \[[@r8],[@r30]\]. Other modes of inheritance have been described, including autosomal recessive mode in families with children of consanguineous parents \[[@r31],[@r32]\]. In our population, the familial cases (19 out of 22) had an autosomal recessive mode of inheritance. This is ideal for linkage analysis to identify the causative gene(s) in our population by focusing on families with multiple affected individuals, preferably in two or more generations.
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